Wednesday, July 2nd, 2025

SATS Ltd Expected to Extend Growth with Strong Q2 Profit Forecast

Date: October 10, 2024
Broker: CGS International Securities Pte. Ltd.


Company Overview

SATS Ltd is a leading provider of food solutions and gateway services, primarily serving the aviation industry. The company is expected to continue its growth trajectory, returning to pre-Covid profitability levels by FY25F.


Q2 FY25F Profit Outlook

  • Estimated Core Net Profit: S$62 million to S$65 million
  • This represents a 7%-12% quarter-on-quarter growth in profit for Q2 FY25F, indicating strong momentum in revenue and profitability.

Earnings and Profitability Forecast

The company’s earnings are expected to rise due to stronger revenue momentum and a favorable tax rate, partially offsetting higher operational expenditures. The broker has raised the EPS forecast for FY25F-FY27F by 7.6%-14.7%.


Return to Pre-Covid Profitability

SATS Ltd is expected to return to its FY19 pre-Covid levels of profitability by FY25F, marking a significant recovery in the company’s operations and financial performance.


Valuation and Target Price

  • DCF-based Target Price: S$4.40
  • This target price is based on a weighted average cost of capital (WACC) of 10.4%.

Investment Recommendation

The broker reiterates an “Add” recommendation for SATS Ltd, suggesting a positive outlook for the company over the next 12 months based on its strong earnings potential.


Analyst Contact


Source: CGS International Securities Pte. Ltd.

DBS Group Holdings: Long-Term Uptrend Intact – Technical Analysis Points to Further Gains

Trendspotter: Singapore Retail Research – November 7, 2024 Trendspotter: Singapore Retail Research Date: November 7, 2024 Broker Name: CGS International Securities Market Overview Donald Trump’s victory in Tuesday’s presidential contest threatens to upend the...

YZJ:$2.56, above ichimoku cloud and a bullish falling wedge. 

YZJ:$2.56, above ichimoku cloud and a bullish falling wedge. Above the Ichimoku Cloud: The Ichimoku Cloud is a popular technical indicator used to gauge momentum, trend direction, and potential support or resistance levels. The...

Sino Biopharmaceutical Ltd Positioned for Strong Gains with Technical Buy Momentum

Date: September 17, 2024Broker: CGS-CIMB Securities Company Overview Sino Biopharmaceutical Ltd (Stock Code: 1177) is a major pharmaceutical company based in Hong Kong. It focuses on the research, development, production, and distribution of biopharmaceutical...